Coronary Artery Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Therefore, we performed this meta-analysis to better explore potential roles of ADIPOQ polymorphisms in CAD.
|
30885128 |
2019 |
Coronary Artery Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Patients with AS and coexisting CAD were characterized by decreased serum adiponectin (9.9 ± 5.5 vs. 12.7 ± 5.8 μg/mL, p = 0.040) and leptin (8.3 ± 7.8 vs. 21.6 ± 17.1 ng/mL, p < 0.001) levels compared to subjects without CAD.
|
29168539 |
2019 |
Coronary Artery Disease
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Lower HMW adiponectin levels were associated with higher body mass index (BMI), higher Framingham risk for coronary heart disease, higher number of metabolic syndrome criteria, greater insulin resistance, lower HDL cholesterol, and higher hs-CRP in both groups.
|
31276836 |
2019 |
Coronary Artery Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Therefore, we performed this meta-analysis to better analyse associations between ADIPOQ polymorphisms and CAD.
|
30879388 |
2019 |
Coronary Artery Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
<b>Conclusion:</b> Elevated levels of CTRP15 in CAD patients and the relation of CTRP15 with pathogenic conditions such as insulin resistance, inflammation, and decreased adiponectin and HDL-C suggest a possible compensatory response to these conditions in CAD patients.
|
31608708 |
2019 |
Coronary Artery Disease
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Likewise, exogenous adiponectin, a known activator of neutral ceramidase, or, activation of adiponectin receptors, favored NO-dependent dilation in arterioles collected from patients with coronary artery disease.
|
31462128 |
2019 |
Coronary Artery Disease
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Compared with the control group, the CAD group displayed significantly higher serum levels of retinol-binding protein-4 (RBP4), pentraxin 3 (PTX3), galectin-3 (GAL-3), and plasminogen activator inhibitor (PAI-1), and significantly lower levels of netrin-1 (NTN1), interleukin-37 (IL-37), and adiponectin (ADP) (all P < 0.05).
|
31464731 |
2019 |
Coronary Artery Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Plasma leptin, but not resistin, TNF-α and adiponectin, is associated with echocardiographic parameters of cardiac remodeling in patients with coronary artery disease.
|
29324260 |
2018 |
Coronary Artery Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Additionally, adiponectin decreased in CAD and T2DM patients as compared to the control group, while IL-6 and TNF-α were higher in CAD and T2DM patients.
|
30212581 |
2018 |
Coronary Artery Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
To investigate the association of plasma adiponectin with virtual histology intravascular ultrasound (VH-IVUS)-derived measures of atherosclerosis and with major adverse cardiac events (MACE) in patients with established coronary artery disease.
|
30379252 |
2018 |
Coronary Artery Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Previous observational studies are likely driven by factors driving both adiponectin and CAD, whose elucidation might provide new insights concerning interventions for CAD.
|
30041791 |
2018 |
Coronary Artery Disease
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Besides, lactate dehydrogenase (LDH) and creatine kinase (CK) downregulation and adiponectin expression play important roles in promoting coronary artery disease.
|
29233027 |
2018 |
Coronary Artery Disease
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Serum adiponectin, insulin resistance and CPR levels are closely related to diabetes mellitus combined with coronary heart disease, and can affect the degree of vascular endothelial injury in coronary heart disease.
|
30186434 |
2018 |
Coronary Artery Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Adiponectin was inversely associated with CAD, and lipoprotein(a) and cystatin C were associated with CAD at coronary CTA.
|
28168796 |
2018 |
Coronary Artery Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Leptin and adiponectin have been linked to the development of coronary heart disease and may be involved in the underlying biological mechanism of ischemic stroke.
|
29278852 |
2018 |
Coronary Artery Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The contribution of adiponectin variants to CAD was analyzed by haplotype and regression analysis.
|
29633340 |
2018 |
Coronary Artery Disease
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
In these patients, low adiponectin and high lipoprotein(a) levels are found which are known to be associated with endothelial dysfunction, atherosclerosis and coronary artery disease.
|
27007665 |
2018 |
Coronary Artery Disease
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Summary odds rations (ORs) and 95% confidence intervals (CIs) were used to evaluate ADIPOQ polymorphisms associations with CAD risk in diabetic group.
|
28881706 |
2017 |
Coronary Artery Disease
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
The aim of the present study was to assess the association of low ADPN plasma levels with the presence of subclinical atherosclerosis in a Mexican-Mestizo population without history of diabetes or coronary artery disease (CAD).
|
28577872 |
2017 |
Coronary Artery Disease
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Circulating levels of adiponectin and extent of coronary artery disease in patients undergoing elective coronary angiography.
|
29211251 |
2017 |
Coronary Artery Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
We present, in this study, an updated meta-analysis to discern the genetic susceptibility of adiponectin SNPs in relation to CAD.
|
28617663 |
2017 |
Coronary Artery Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
We also focus on the links between adiponectin and lipid disorders and with coronary heart disease and noncardiac vascular diseases (i.e. stroke, peripheral artery disease, carotid artery disease, atherosclerotic renal artery stenosis, abdominal aortic aneurysms and chronic kidney disease).
|
28463859 |
2017 |
Coronary Artery Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Leptin to insulin and adiponectin to endothelin ratios are novel derived biomarkers useful for noninvasive diagnostics of initial stages of coronary lesions in patients with coronary artery disease.
|
27300270 |
2017 |
Coronary Artery Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
Adiponectin and leptin are the commonest adipocytokines and have been invariably linked to the development of coronary heart disease and may be involved in the underlying biological mechanism of stroke.
|
28121618 |
2017 |
Coronary Artery Disease
|
0.100 |
Biomarker
|
disease |
BEFREE |
The results revealed that total and HMW Apn derived from blood samples of CAD patients with severe stenosis significantly increased, however the glycosylation of HMW Apn significantly decreased.
|
28848139 |
2017 |